Diseases, Conditions, Syndromes

No need to avoid statins in hep C compensated cirrhosis

(HealthDay)—Statin use is associated with decreased risk of cirrhosis decompensation and death in patients with hepatitis C virus (HCV)-related compensated cirrhosis, according to research published in the February issue ...

Cardiology

Paracentesis underutilized in patients with cirrhosis, ascites

(HealthDay)—For patients admitted with diagnoses of cirrhosis and ascites, paracentesis is associated with decreased in-hospital mortality but is underutilized, according to a study published online Dec. 8 in the Journal ...

Diseases, Conditions, Syndromes

Scientists discover a potential treatment for cirrhosis

A study by IRB Barcelona and IDIBAPS reveals a therapeutic target to prevent the development of the many abnormal blood vessels that cause gastrointestinal bleeding—the main complication in cirrhosis.

Diseases, Conditions, Syndromes

Low-dose rifaximin cuts endotoxin level in cirrhosis

(HealthDay)—For patients with liver cirrhosis, low-dose rifaximin is comparable to high-dose rifaximin for reducing serum endotoxin levels, according to a study published online Oct. 16 in the Journal of Digestive Diseases.

Diseases, Conditions, Syndromes

Liver damage in hepatitis C patients significantly underestimated

The number of hepatitis C patients suffering from advanced liver damage may be grossly underestimated and underdiagnosed, according to a study led by researchers at Henry Ford Health System and the U.S. Centers for Disease ...

Diseases, Conditions, Syndromes

Technivie approved for hepatitis C

(HealthDay)—Technivie (ombitasvir, paritaprevir and ritonavir) has been approved by the U.S. Food and Drug Administration, in tandem with ribavirin, to treat hepatitis C genotype 4 infection among people without poor liver ...

Diseases, Conditions, Syndromes

Research addresses the burden of liver disease

Chronic liver diseases are steadily growing conditions, estimated to affect one in 10 Canadians.  Most chronic liver diseases are "silent", attacking the liver for decades without symptoms until revealing themselves through ...

page 12 from 17